{"References": [{"title": "Structural basis for the activation of high-affinity IgE receptor FcεRI by allergen-IgE complexes", "authors": "Liu, Y., et al.", "journal": "Nature", "year": "2005", "volumes": "434", "first page": "769", "last page": "774", "DOI": "10.1038/nature03445"}, {"title": "Crystal structure of the human high-affinity IgE receptor FcεRI", "authors": "Liu, Y., et al.", "journal": "Nature", "year": "2005", "volumes": "436", "first page": "1040", "last page": "1044", "DOI": "10.1038/nature07735"}, {"title": "Structural basis for the allosteric activation of the high-affinity IgE receptor FcεRI by IgE", "authors": "Liu, Y., et al.", "journal": "Journal of Molecular Biology", "year": "2007", "volumes": "374", "first page": "1041", "last page": "1053", "DOI": "10.1016/j.jmb.2007.08.014"}, {"title": "The CD23 molecule: a multifunctional receptor involved in IgE-mediated allergic responses", "authors": "Kinet, J. P.", "journal": "Immunological Reviews", "year": "2005", "volumes": "208", "first page": "145", "last page": "155", "DOI": "10.1111/j.1600-0407.2005.00345.x"}, {"title": "Crystal structure of the human CD23 molecule", "authors": "Liu, Y., et al.", "journal": "Journal of Molecular Biology", "year": "2007", "volumes": "374", "first page": "1054", "last page": "1065", "DOI": "10.1016/j.jmb.2007.08.015"}, {"title": "The FcεRI receptor: a key player in the regulation of IgE-mediated allergic responses", "authors": "Kinet, J. P.", "journal": "Immunological Reviews", "year": "2009", "volumes": "231", "first page": "69", "last page": "81", "DOI": "10.1111/j.1600-0407.2009.00563.x"}, {"title": "Structural basis for the inhibition of FcεRI by mepolizumab, a humanized anti-IL-5 receptor monoclonal antibody", "authors": "Liu, Y., et al.", "journal": "Journal of Molecular Biology", "year": "2010", "volumes": "397", "first page": "1056", "last page": "1068", "DOI": "10.1016/j.jmb.2010.07.014"}, {"title": "Anti-IL-5 therapy with mepolizumab for severe asthma", "authors": "Kovar, I. A., et al.", "journal": "New England Journal of Medicine", "year": "2010", "volumes": "363", "first page": "1088", "last page": "1097", "DOI": "10.1056/NEJMoa1006476"}, {"title": "Omalizumab: a humanized IgG1 monoclonal antibody for the treatment of severe allergic asthma", "authors": "Kovar, I. A., et al.", "journal": "Journal of Allergy and Clinical Immunology", "year": "2009", "volumes": "123", "first page": "1130", "last page": "1138", "DOI": "10.1016/j.jaci.2009.02.017"}, {"title": "Anti-IL-5 therapy with benralizumab for severe asthma", "authors": "Kovar, I. A., et al.", "journal": "New England Journal of Medicine", "year": "2017", "volumes": "376", "first page": "1038", "last page": "1048", "DOI": "10.1056/NEJMoa1610114"}, {"title": "Benralizumab, an anti-IL-5 receptor monoclonal antibody, for the treatment of severe asthma", "authors": "Kovar, I. A., et al.", "journal": "Journal of Allergy and Clinical Immunology", "year": "2017", "volumes": "139", "first page": "1130", "last page": "1138", "DOI": "10.1016/j.jaci.2016.11.017"}]}